Tag: Weight loss medications
-
GLP-1 Drugs Ozempic Wegovy May Cut Cancer Death Risk in Obese Patients
New findings spark debate about GLP-1 drugs and cancer outcomes A recent study exploring the impact of GLP-1 receptor agonists, including popular weight loss drugs Ozempic and Wegovy, has drawn attention for potential improvements in cancer survival. While the research is early and observational in nature, it suggests that patients using these medications may experience…
-
Unusual GLP-1 Drug Side Effect Could Skew PET-CT Scans, Study Warns
GLP-1 drugs are reshaping weight loss—and now imaging, too GLP-1 receptor agonists, best known by brand names like Ozempic, Wegovy, and Mounjaro, have surged in popularity for their powerful weight‑loss effects. But as their use has exploded—driven by a 700% rise in the United States from 2019 to 2023—so too have reports of unusual side…